Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-17

Clinical Trial Update: Growth Hormone to Increase Immune Function in People With HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating growth hormone to boost immune function in people with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED